Skip to main content

SiderAL® is the ONLY Sucrosomial® Iron, now available in Canada

Non-inferior to IV iron¹ with virtually no side-effects, < 4.5%²

  1. Giordano G, Napolitano M, Di Battista V, Lucchesi A. Oral high-dose sucrosomial iron vs intravenous iron in sideropenic anemia patients intolerant/refractory to iron sulfate: a multicentric randomized study. Ann Hematol. 2021 Sep;100(9):2173-2179. doi: 10.1007/s00277-020-04361-3. Epub 2020 Dec 2. PMID: 33263170; PMCID: PMC8357646.
  2. Gómez-Ramírez S, Brilli E, Tarantino G, Girelli D, Muñoz M. Sucrosomial® Iron: An Updated Review of Its Clinical Efficacy for the Treatment of Iron Deficiency. Pharmaceuticals (Basel). 2023 Jun 6;16(6):847. doi: 10.3390/ph16060847. PMID: 37375794; PMCID: PMC10305423.

    SiderAL® : an innovative technology serving your health.

    From our research laboratories, this is a unique and exclusive technology for overcoming the limits of daily oral iron supplementation.

    When SiderAL® is used

    The World Health Organization (WHO) has estimated that 2 billion people worldwide have a iron deficiency, making this the most widespread nutritional problem globally. SiderAL® is the only iron recognized by the WHO for the treatment of iron deficiency in cardiovascular and diabetic patients³

    3. Guidance on implementing patient blood management to improve global blood health status